You're signed outSign in or to get full access.
Medicxi Ventures Management (jersey) LTD
Medicxi is a European investment firm specializing in life sciences sector investments, with a focus on supporting biotech and pharmaceutical companies at various stages of development, from seed to late-stage
Investment Strategy
Life sciences and healthcare equity investments, particularly in biotech and pharmaceutical companies, leveraging both early-stage innovation and opportunities in clinical and commercial development
Latest 13F Filing Activity
Medicxi Ventures Management (jersey) LTD filed their most recent 13F report on Sep 30, 2025 disclosing 4 equity positions with a total 13F market value of $744M. The fund increased holdings in Centessa Pharmaceuticals PLC, Newamsterdam Pharma Company, Phathom Pharmaceuticals Inc. among other positions. Medicxi Ventures Management (jersey) LTD reduced exposure to Rapt Therapeutics Inc., Aura Biosciences Inc., Phathom Pharmaceuticals Inc. among others.
Top Holdings
Equity Positions (4)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CNTA | CENTESSA PHARMACEUTICALS PLC | 65.03% | $484.1M | 19,963,157 | $20.88 | $24.25 | +$221.8M |
P PHAT | PHATHOM PHARMACEUTICALS INC | 11.80% | $87.9M | 7,464,572 | $16.82 | $11.77 | +$16.3M |
N NAMS | NEWAMSTERDAM PHARMA COMPANY | 10.96% | $81.6M | 2,869,565 | $11.20 | $28.44 | +$29.6M |
A AURA | AURA BIOSCIENCES INC | 2.52% | $18.8M | 3,039,892 | $16.98 | $6.18 | -$243.2K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more